"Medicine of high price" drops to "floor price" medicine environment is gentle

January 9, medical network news let people cut practical on the good medicine, can use this good medicine, to the entire pharmaceutical industry ecological environment purification, for example, to eliminate the sales with money with quantity purchase, through medical insurance prepayment, hospital balance incentive, can create a new relatively healthy interest mechanism Qi Qingju, a citizen of Jinan, has peritoneal cancer and needs to take olapari for a long time Before olapali, the market price was 24790 yuan for one box Two boxes are needed every month, and the cost is nearly 50000 yuan It's hard for a working family to afford Since January 1 this year, the new version of the national medical insurance catalog has been officially launched 97 drugs, including olapaley, have been negotiated into the new version of the national medical insurance catalog Not only has the price been reduced, it can also be included in the medical insurance reimbursement This brings hope to the qiqingju family Qi Qingju said she was looking forward to the day Qi Qingju's daughter calculated an account for the reporter The money for the medicine for curing the disease has come down, and the burden of the family has been reduced Qi Qingju's daughter said: "more than 9400 boxes (after the price reduction), so after two boxes of medicine are reimbursed in one month, the individual only needs to bear 3800 yuan (per month) In this way, there must be no problem with our family's money for medicine, and the quality of life will certainly improve " The official launch of the new version of the national medical insurance drug catalog enables patients to truly enjoy the benefits of part of the "floor price of high priced drugs" At zero on January 1, major hospitals in Beijing completed the upgrading and updating of hospital information system A total of 2643 drugs that have passed the routine access and 97 drugs that have entered through the medical insurance negotiation have been included in the medical insurance catalogue, and the burden of patients has been greatly reduced Fu Jinglin, a citizen who took medicine in a hospital in Beijing, said happily, "before 5700 yuan, now we have medical insurance, we can use this medicine for hundreds of yuan." Zhang Tongyan, director of the medical insurance office of Beijing Tongren Hospital Affiliated to Capital Medical University, told reporters that the biggest adjustment of the medical insurance drug catalog was the obvious decrease, "about 60% of the price reduction." According to the calculation, in the new version of the medical insurance catalogue, the average decline of drugs negotiated to enter the medical insurance was 60.7%, and some imported drugs even offered the lowest price in the world For example, the drugs included in the medical insurance catalogue to treat hepatitis C are global good drugs As long as one pill is taken every day for 12 consecutive weeks, the cure rate of hepatitis C virus will reach more than 98% In the newly added list of 70 drugs, three drugs for hepatitis C treatment were included in the new version of the national basic medical insurance, work injury insurance and maternity insurance drug catalog for the first time, with an average price reduction of more than 85%, covering all genotypes of patients Xiong Xianjun, director of the medical service management department of the State Medical Security Bureau, said: "it also needs to link up with the existing reimbursement policies Some may be included in the general outpatient service, some may be included in the outpatient chronic disease, some may be paid according to the disease type, and different places." Before that, the high drug price made many patients flinch Just after the publication of the new catalogue, Kunming Third People's hospital began to implement the new price of hepatitis C drugs The original price of the drug for the treatment of all patients with hepatitis C genotype was reduced from 70000 yuan to 13000 yuan In less than ten days, the drugs for hepatitis C in the hospital were selling short Li Junyi, chief physician of Kunming Third People's Hospital, said: "because of this cost, many patients did not see a doctor in time A course of treatment costs at least 70000 yuan, which is a great economic burden for patients." The enthusiasm of pharmaceutical companies is not reduced The pharmaceutical environment is clean The price of drugs has been reduced The people have a long sigh of relief But what do pharmaceutical companies think? Will low drug prices hit the enthusiasm of enterprises in R & D and production? Guo Jia, chairman of Xi'an Dongsheng Group Co., Ltd., said that to some extent, volume purchasing has become the driving force to stimulate the R & D and production of pharmaceutical enterprises "The mode of strong promotion in hospitals may have come to an end I think these traditional generic pharmaceutical enterprises may face a very cruel encounter in the future, that is, if they cannot participate in the bidding and fail to win the final bid, they may soon be eliminated by the market." The reporter combed and found that even if the price of drugs dropped sharply, some of the products have achieved different levels of volume reduction after entering the medical insurance For example, for the products in the field of tumor, the volume effect is more considerable, and the volume of some drugs even reached 180 times in the second year after entering the medical insurance Zhong Dongbo, director of the medical price and bidding procurement department of the state health insurance bureau, said, "after this reform, the transaction cost of enterprises has been reduced Enterprises do not need to carry gold sales, so they can all collect money in time." Ye Yin, chief analyst of the pharmaceutical industry at Ping An Securities Research Institute, also believes that it is a rational choice for enterprises to trade volume for price "After entering the medical insurance market with volume for price, its sales volume must be guaranteed Many of them have been on the market for a long time, so they will also face the competition of similar varieties or the impact of biological analogues and generic drugs at present," Ye Yin said So for these enterprises, it's also a rational choice for them to reduce the price of medical insurance and quickly seize the Chinese market " On January 17, the second batch of drugs will be purchased in volume This time, 33 varieties and hundreds of pharmaceutical companies are involved in the volume purchase, among which the prices of chronic diseases such as hypertension and diabetes are expected to be greatly reduced It is expected that in April this year, patients in the whole country will use the second batch of national centralized procurement of selected drugs Chen Jinfu, deputy director of the National Medical Security Bureau, said that with the volume of procurement, people can use good drugs and create a healthy medical environment "It can make the common people practically use the good medicine, can afford this kind of good medicine, and purify the ecological environment of the whole pharmaceutical industry For example, we can eradicate the sales of carrying gold with volume purchase, and create a new and healthy benefit mechanism through medical insurance prepayment and balance incentive of the hospital."